Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896934879> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2896934879 abstract "To compare the frequency, clinical features and outcomes of renal involvement in ANCA-associated vasculitides (AAV) in patients with antibodies against proteinase-3 (pr3-ANCA) and myeloperoxidase (MPO-ANCA).In our retrospective study we enrolled 264 patients, 94 males and 170 females, median age 53 [36; 62] years. Among them 157 were pr3-ANCA positive and 107 were MPO-ANCA positive. AAV was diagnosed according to ACR criteria and Chapel Hill consensus conference definition (2012). Median follow up was 44 [18; 93] months. We assessed baseline BVAS and VDI by the end of the follow up. Serum creatinine (sCr), estimated glomerular filtration rate (eGFR), hematuria and daily proteinuria were estimated. Diagnosis and stage of chronic kidney disease (CKD) and acute kidney injury (AKI) were established according to KDIGO guidelines (2012) and Scientific Society of Russian Nephrologists (2016).Renal involvement was present in 181 (68.6%) patients, and its frequency was similar in pr3-ANCA and MPO-ANCA subgroups. Patients with MPO-ANCA developed rapidly progressive glomerulonephritis and hypertension significantly more often than patients with pr3-ANCA: 50.7% vs 35.6% (p=0.049) and 46.1% vs 29.8% (p=0.029) respectively. At disease onset, median sCr was significantly higher and eGFR was significantly lower in patients with MPO-ANCA (p<0.05). 1-year and 5-year renal survival rates were similar in pr3-ANCA-positive (93.9% and 87.4% respectively) and MPO-ANCA positive patients (87.4% and 83.1% respectively). Median BVAS and VDI scores were significantly higher in pr3-ANCA subgroup. The number of patients who developed AAV relapse during 1-year follow up was also significantly higher in pr3-ANCA subgroup. The frequency of eye and ENT involvement was significantly higher in pr3-ANCA positive patients than in MPO-ANCA-positive patients.The frequency of extrarenal manifestations, clinical features of renal involvement and relapse rate are associated with AAV serotype." @default.
- W2896934879 created "2018-10-26" @default.
- W2896934879 creator A5009125671 @default.
- W2896934879 creator A5037071862 @default.
- W2896934879 creator A5039650454 @default.
- W2896934879 creator A5040482802 @default.
- W2896934879 creator A5043669000 @default.
- W2896934879 creator A5044806361 @default.
- W2896934879 creator A5046505982 @default.
- W2896934879 creator A5057507850 @default.
- W2896934879 creator A5066278285 @default.
- W2896934879 creator A5070299377 @default.
- W2896934879 creator A5072832856 @default.
- W2896934879 creator A5074379011 @default.
- W2896934879 creator A5079058999 @default.
- W2896934879 creator A5082746118 @default.
- W2896934879 creator A5086876583 @default.
- W2896934879 creator A5088048652 @default.
- W2896934879 date "2018-06-15" @default.
- W2896934879 modified "2023-09-27" @default.
- W2896934879 title "Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides" @default.
- W2896934879 doi "https://doi.org/10.26442/terarkh201890615-21" @default.
- W2896934879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30701899" @default.
- W2896934879 hasPublicationYear "2018" @default.
- W2896934879 type Work @default.
- W2896934879 sameAs 2896934879 @default.
- W2896934879 citedByCount "5" @default.
- W2896934879 countsByYear W28969348792020 @default.
- W2896934879 countsByYear W28969348792021 @default.
- W2896934879 countsByYear W28969348792022 @default.
- W2896934879 crossrefType "journal-article" @default.
- W2896934879 hasAuthorship W2896934879A5009125671 @default.
- W2896934879 hasAuthorship W2896934879A5037071862 @default.
- W2896934879 hasAuthorship W2896934879A5039650454 @default.
- W2896934879 hasAuthorship W2896934879A5040482802 @default.
- W2896934879 hasAuthorship W2896934879A5043669000 @default.
- W2896934879 hasAuthorship W2896934879A5044806361 @default.
- W2896934879 hasAuthorship W2896934879A5046505982 @default.
- W2896934879 hasAuthorship W2896934879A5057507850 @default.
- W2896934879 hasAuthorship W2896934879A5066278285 @default.
- W2896934879 hasAuthorship W2896934879A5070299377 @default.
- W2896934879 hasAuthorship W2896934879A5072832856 @default.
- W2896934879 hasAuthorship W2896934879A5074379011 @default.
- W2896934879 hasAuthorship W2896934879A5079058999 @default.
- W2896934879 hasAuthorship W2896934879A5082746118 @default.
- W2896934879 hasAuthorship W2896934879A5086876583 @default.
- W2896934879 hasAuthorship W2896934879A5088048652 @default.
- W2896934879 hasBestOaLocation W28969348791 @default.
- W2896934879 hasConcept C126322002 @default.
- W2896934879 hasConcept C159641895 @default.
- W2896934879 hasConcept C159654299 @default.
- W2896934879 hasConcept C203014093 @default.
- W2896934879 hasConcept C21194631 @default.
- W2896934879 hasConcept C24040308 @default.
- W2896934879 hasConcept C2775998817 @default.
- W2896934879 hasConcept C2776015282 @default.
- W2896934879 hasConcept C2778653478 @default.
- W2896934879 hasConcept C2779134260 @default.
- W2896934879 hasConcept C2779561371 @default.
- W2896934879 hasConcept C2780091579 @default.
- W2896934879 hasConcept C2780306776 @default.
- W2896934879 hasConcept C2780368995 @default.
- W2896934879 hasConcept C45189115 @default.
- W2896934879 hasConcept C71924100 @default.
- W2896934879 hasConcept C90924648 @default.
- W2896934879 hasConceptScore W2896934879C126322002 @default.
- W2896934879 hasConceptScore W2896934879C159641895 @default.
- W2896934879 hasConceptScore W2896934879C159654299 @default.
- W2896934879 hasConceptScore W2896934879C203014093 @default.
- W2896934879 hasConceptScore W2896934879C21194631 @default.
- W2896934879 hasConceptScore W2896934879C24040308 @default.
- W2896934879 hasConceptScore W2896934879C2775998817 @default.
- W2896934879 hasConceptScore W2896934879C2776015282 @default.
- W2896934879 hasConceptScore W2896934879C2778653478 @default.
- W2896934879 hasConceptScore W2896934879C2779134260 @default.
- W2896934879 hasConceptScore W2896934879C2779561371 @default.
- W2896934879 hasConceptScore W2896934879C2780091579 @default.
- W2896934879 hasConceptScore W2896934879C2780306776 @default.
- W2896934879 hasConceptScore W2896934879C2780368995 @default.
- W2896934879 hasConceptScore W2896934879C45189115 @default.
- W2896934879 hasConceptScore W2896934879C71924100 @default.
- W2896934879 hasConceptScore W2896934879C90924648 @default.
- W2896934879 hasLocation W28969348791 @default.
- W2896934879 hasLocation W28969348792 @default.
- W2896934879 hasOpenAccess W2896934879 @default.
- W2896934879 hasPrimaryLocation W28969348791 @default.
- W2896934879 hasRelatedWork W1971436740 @default.
- W2896934879 hasRelatedWork W2080656589 @default.
- W2896934879 hasRelatedWork W2105083673 @default.
- W2896934879 hasRelatedWork W2184243264 @default.
- W2896934879 hasRelatedWork W2233918100 @default.
- W2896934879 hasRelatedWork W2343970023 @default.
- W2896934879 hasRelatedWork W2416141913 @default.
- W2896934879 hasRelatedWork W2738848803 @default.
- W2896934879 hasRelatedWork W2909423711 @default.
- W2896934879 hasRelatedWork W2974900340 @default.
- W2896934879 isParatext "false" @default.
- W2896934879 isRetracted "false" @default.
- W2896934879 magId "2896934879" @default.
- W2896934879 workType "article" @default.